In 2023, CR Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, CR Medical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020-2019 |
|---|---|---|---|---|
Total Scope 1 | 1,359.06a | 7,507.73a | 5,126.59a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 175,753.72a | 68,146.52a | 53,082.63a | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.9556a | 6.6163a | 7.3451a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of CR Medical amounted to 177,112.78 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CR Medical increased by 134.11%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2023, the total Scope 1 emissions of CR Medical were 1,359.06 metric tons of CO₂ equivalent (tCO₂e).a
Since 2020, CR Medical's Scope 1 emissions have decreased by 75.91%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2022), CR Medical's Scope 1 emissions decreased by 81.9%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2023, CR Medical reported Scope 2 greenhouse gas (GHG) emissions of 175,753.72 tCO₂e without specifying the calculation method.a
Since 2020, CR Medical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 111.6%, reflecting a rising long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2022), CR Medical's Scope 2 emissions (Unspecified Calculation Method) rose by 157.91% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2023, CR Medical reported its Scope 2 emissions using an unspecified methodology.a
In 2023, CR Medical reported Scope 1 greenhouse gas (GHG) emissions of 1,359.06 tCO₂e and total revenues of USD 1,422 millions. This translates into an emissions intensity of 0.96 tCO₂e per millions USD.a
In 2023, CR Medical reported a Scope 1 emissions intensity of 0.96 tCO₂e per millions USD. Compared to the peer group median of 4.67, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2023, CR Medical ranked 7 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
CR Medical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a